Skip to main content
. 2017 May 9;12(5):e0177015. doi: 10.1371/journal.pone.0177015

Table 2. Clinical variables for predicting EGFR activating mutations: Multiple logistic regression analysis results.

Variables ORs 95% CIs P
Family history of lung cancer (yes v no) 2.01 1.18–3.60 0.011
Age (increasing) 1.00 0.98–1.01 0.947
Gender (female v male) 2.07 1.20–3.61 0.011
Smoking habit (never v ever smoker) 2.64 1.50–4.67 0.001
ECOG performance status (0–1 v 2–4) 0.97 0.65–1.46 0.893
Body mass index (< 22.4 v ≥ 22.4) 1.03 0.72–1.47 0.872
Histology (adenocarcinoma v non-adenocarcinoma) 3.60 2.31–5.60 < 0.001
Stages (I and II v III and IV) 1.23 0.84–1.81 0.291

ECOG = Eastern Cooperative Oncology Group; Body mass index by 22.4 of median value